ANNE TSAO to Mutagenesis, Insertional
This is a "connection" page, showing publications ANNE TSAO has written about Mutagenesis, Insertional.
Connection Strength
0.044
-
Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial. Cancer Discov. 2021 07; 11(7):1688-1699.
Score: 0.044